Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18745588 | 0.85 | ALDH1A1 (0.38) | — | |
| SCHEMBL9019396 | 0.84 | — | — | |
| SCHEMBL12321790 | 0.84 | — | — | |
| SCHEMBL25478332 | 0.78 | GRIK1 (0.32) | GRIK1 | |
| SCHEMBL7636887 | 0.78 | GRIK1 (0.32) | GRIK1 | |
| SCHEMBL7636890 | 0.78 | GRIK1 (0.32) | GRIK1 | |
| SCHEMBL20251097 | 0.77 | — | — | |
| SCHEMBL18069618 | 0.74 | — | — | |
| SCHEMBL5088912 | 0.73 | GRIK1 (0.35) | GRIK1GRIK2 | |
| SCHEMBL26080809 | 0.72 | GRIK1 (0.44) | GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230007940-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCKP PATENT GMBH (DE) | 2023-01-12 | — | — | US | disclosed |
| US-20210087469-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2021-03-25 | — | — | US | disclosed |
| US-10351771-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2019-07-16 | — | — | US | disclosed |
| US-9944416-B2 | Filling device and use thereof for dispensing a fluid | MERCK PATENT GMBH (DE) | 2018-04-17 | — | — | US | disclosed |
| US-20170037316-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-09 | — | — | US | disclosed |
| CN-102557863-A | Preparation method of difluoro-vinyl cyclohexane derivatives | SHANGHAI SINOFLUORO SCIENT CO | 2012-07-11 | — | — | CN | disclosed |
| CN-102557863-A | Preparation method of difluoro-vinyl cyclohexane derivatives | SHANGHAI SINOFLUORO SCIENT CO | 2012-07-11 | — | — | CN | disclosed |
| US-7030283-B2 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-7030283-B2 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-20050165260-A1 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | VERSUM MATERIALS US, LLC | 2005-07-28 | — | — | US | disclosed |
| US-20050165260-A1 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | VERSUM MATERIALS US, LLC | 2005-07-28 | — | — | US | disclosed |
| EP-1557404-A1 | Process for producing 1,1-Difluorovinyl cycloaliphatic compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-07-27 | — | — | EP | disclosed |
| EP-1557404-A1 | Process for producing 1,1-Difluorovinyl cycloaliphatic compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037316-A1 | LIQUID-CRYSTALLINE MEDIUM | FES, NEFM, SOST | GRIK1 2625/4885GRIK2 3982/4885 |
| US-20050165260-A1 | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | KMO, KCNB1, KCNB2 | GRIK1 129/4885GRIK2 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.